These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6863981)

  • 1. In vivo mobilization of polymorphonuclear leukocytes in psoriasis: relationship to clinical parameters and serum inhibitory factors.
    Tigalonowa M; Glinski W; Jablonska S
    J Invest Dermatol; 1983 Jul; 81(1):6-9. PubMed ID: 6863981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythm of the in vivo migration of neutrophils in psoriatic patients.
    Pigatto PD; Radaelli A; Tadini G; Polenghi MM; Brambilla L; Altomare G; Carandente F
    Arch Dermatol Res; 1985; 277(3):185-9. PubMed ID: 4015183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil leukocyte migration in psoriasis vulgaris.
    Breathnach SM; Carrington P; Black MM
    J Invest Dermatol; 1981 Apr; 76(4):271-4. PubMed ID: 7205028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils.
    Majewski S; Jabłonska S; Langner A; Pawinska M; Szmurło A
    Br J Dermatol; 1985 Jun; 112(6):655-62. PubMed ID: 4038367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriatic sera decrease responses of stimulated granulocytes from normal and psoriatic subjects.
    Camisa C; Kraut E; Jayanthi-Zvara B
    J Invest Dermatol; 1984 Apr; 82(4):318-21. PubMed ID: 6323586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration-stimulating effect of psoriatic scales on polymorphonuclear leukocytes.
    Lidén S; Bäck O; Pettersson A
    Arch Dermatol Res; 1980; 269(1):93-8. PubMed ID: 7447494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 receptors in normal and psoriatic polymorphonuclear leukocytes.
    Arenberger P; Kemény L; Süss R; Michel G; Peter RU; Ruzicka T
    Acta Derm Venereol; 1992 Sep; 72(5):334-6. PubMed ID: 1361277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.
    Guillot B; Coupe M; Alirezai M; Bureau JP; Guilhou JJ
    Arch Dermatol Res; 1989; 280(8):477-80. PubMed ID: 2645836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
    Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
    J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis.
    Glinski W; Zarebska Z; Jabłonska S; Imiela J; Nosarzewski J
    J Invest Dermatol; 1980 Dec; 75(6):481-7. PubMed ID: 6777433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?
    Langner A; Chorzelski TP; Fraczykowska M; Jabłońska S; Symańczyk
    Arch Dermatol Res; 1983; 275(4):226-8. PubMed ID: 6625647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of serum from patients with psoriasis on in vivo mobilization of polymorphonuclear leukocytes].
    Tigałonowa M; Gliński W; Jabłońska S; Szreder I
    Przegl Dermatol; 1983; 70(5-6):461-8. PubMed ID: 6366924
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers.
    Sonnex TS; Carrington P; Norris P; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):653-9. PubMed ID: 3207619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Pease CT; Fennell M; Staughton RC; Brewerton DA
    Br J Dermatol; 1987 Aug; 117(2):161-7. PubMed ID: 3651338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte migration in vivo and in vitro in patients with psoriasis.
    Scheja A; Bruze M; Forsgren A
    Acta Derm Venereol; 1987; 67(5):427-32. PubMed ID: 2448995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.